Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
Clinical trial NCT00169169 · TERMINATED
Trial details
- NCT number
- NCT00169169
- Sponsor
- Lymphoma Study Association
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-10-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.